Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLY II Trial: Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy
NCT06949228Phase 3Recruiting
- Sponsor
- Promedica International
- Start
- Jul 2025
- Primary completion
- May 2028
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Promedica International. Started Jul 2025; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06949228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06949228.